Syra Health Corp
SYRA· OTC
SYRASyra Health Corp
Filed May 9, 2024 · 10-Q · 39 days after period end · 0001493152-24-018382
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Revenue | $1.75M | $1.19M |
| Net Income | -$1.45M | -$785.89K |
| EPS Diluted | -$0.22 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syra Health Corp · CIK 1922335 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 9, 2024 · 39 d after period end
